Smoking tobacco is so harmful to the body that it changes a person’s immune system, leaving them vulnerable to more disease and infection even years after they’ve quit, a new study found.
Although smoking rates have been declining since the 1960s, it’s still the leading cause of preventable death in the United States, causing more than 480,000 deaths each year.
For decades, health care providers have told smokers that the habit can lead to serious problems like lung cancer, heart attack or stroke, but a study published Wednesday in the journal Nature offers another reason to quit.
The CDC ad campaign, Tips from Former Smokers, shares emotional, sometimes harrowing, stories of former smokers, aiming to encourage people to quit smoking.
The research shows how smoking decreases the body’s ability to fight off infection immediately and over time, and may also put someone at risk of chronic diseases involving inflammation, such as rheumatoid arthritis and lupus.
“Stop smoking as soon as possible,” warned study co-author Dr. Violaine Saint-André, a specialist in computational biology at Institut Pasteur in Paris. “The key message of our study, especially to the youth, is that there seems to be a significant interest for long-term immunity to never start smoking.”
The researchers looked over time at blood samples from a group of 1,000 healthy people ages 20 to 69. The group was equally divided between men and women.
The researchers wanted to see how 136 variables including lifestyle, socioeconomic issues and dietary habits – in addition toage, sex and genetics – affected immune response. They exposed the blood samples to common germs like E. coli bacteria and the flu virus and measured the immune response.
Smoking, body mass index and a latent infection caused by the herpes virus had the most impact, with smoking creating the biggest change. It had nearly the same impact on immune response as important factors such as age or sex.
“It’s considerable,” Saint-André said.
When smokers in the study quit, their immune response got better at one level, but it didn’t completely recover for years, according to study co-author Dr. Darragh Duffy, who leads the Translational Immunology unit at the Institut Pasteur.
“The good news is, it does begin to reset,” he said. “It’s never a good time to start smoking, but if you’re a smoker, the best time to stop is now.”
The study also found that the more someone smoked, the more it changed their immune response.
“Cutting down any amount is still a good thing in terms of this impact,” Duffy said.
Smoking, the study found, seemed to have long-term epigenetic effects on the immune system’s two major forms of protection: the innate response and the adaptive response. The effect on the innate response quickly goes away when someone stops smoking, but the effect on the adaptive response persists even after they quit.
The innate immune response is the general way the skin, mucous membranes, immune system cells and proteins fights germs. It’s a fast mover, but it’s a blunt instrument. When the body determines that the innate response isn’t protective enough, the adaptive immune system kicks in. It is made of antibodies in the blood and other bodily fluids, B and T lymphocytes that can “remember” a threat and better target threats it’s seen before.
“The major discovery of our study is that smoking has short-term but also long-term effects on adaptive immunity associated with B cells and regulatory T cells and with epigenetic changes,” Saint-André said.
The new research has some limitations. The experiment was done in blood samples in the lab, but the immune system may react differently in real life. However, human challenge studies are still relatively limited in size compared with what they were able to show with a large collection of blood samples, Duffy says.
Dr. Yasmin Thanavala, a professor of oncology in the Department of Immunology at the Roswell Park Cancer Institute, whose smoking immune response research was referenced in the new study, said the work was “a wonderful validation” of what her research has found over the years.
Thanavala’s research exposed mice to smoke instead of human blood. Those mice cleared a bacterial infection less efficiently and with a less-robust immune response than mice that weren’t exposed. Changes in the lungs subside, she said, but “never go away.”
She points to one limitation in the new study that she hopes researchers will address going forward: the homogeneity of the participants, who were all French and did not have high body weights.
“We know that numerous things besides smoking impacts our immune response. Our genetic background impacts our immune response. There’s also increasing evidence that our body weight, obesity, impacts immune response,” Thanavala said.
Dr. Albert Rizzo, chief medical officer of the American Medical Association, said that doctors have long known that smoking leads to inflammation in the lung but that that doesn’t account for all the problems with the immune system.
It also seems to explain why even smokers who may have quit may still develop conditions like chronic obstructive pulmonary disease or COPD.
“This study is helpful since it tells us what we’ve always thought but now starts to explain the why,” said Rizzo, who wasn’t involved with the new research.